HAL (France)open access
Comment prévenir et gérer les toxicités hématologiques liées aux inhibiteurs de PARP dans le cancer de la prostate ?
Delphi consensus, Anaemia, 0, Prostate cancer, Hematological toxicities, PARP inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1134127
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.